Sensei Biotherapeutics (NASDAQ:SNSE) Releases Earnings Results

Sensei Biotherapeutics (NASDAQ:SNSE) announced its quarterly earnings data on Friday. The company reported ($0.27) EPS for the quarter, meeting the consensus estimate of ($0.27), Zacks reports.

Sensei Biotherapeutics Stock Up 18.0 %

NASDAQ SNSE traded up $0.08 during trading on Friday, hitting $0.51. 145,672,542 shares of the stock traded hands, compared to its average volume of 898,433. The company has a market capitalization of $12.78 million, a P/E ratio of -0.43 and a beta of 0.16. Sensei Biotherapeutics has a 12-month low of $0.38 and a 12-month high of $1.94. The firm has a 50-day simple moving average of $0.47 and a 200-day simple moving average of $0.49.

Analyst Ratings Changes

SNSE has been the topic of several research analyst reports. Oppenheimer boosted their price objective on Sensei Biotherapeutics from $3.50 to $4.00 and gave the company an “outperform” rating in a research report on Friday. HC Wainwright restated a “buy” rating and issued a $4.00 price target on shares of Sensei Biotherapeutics in a research note on Friday.

Sensei Biotherapeutics Company Profile

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.